Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

University of Calgary

$50,000.00

Autonomous microfluidic electrochemical nano-biosensors for highly sensitive and selective detection and monitoring of biomarkers

EF 2021-22

Résumé
The present point-of-care assays and devices developed for rapid detection of biofluid markers are dealing with at least one of the challenges of automation, multiplexing, quantitative measurement, reproducibility, scalability, or cost. This project aims to develop a new scalable and reproducible CApillary Microfluidic Electrochemical Nano-biosensing (CAMEN) platform which enables full automation of complex quantitative bioassays for low-cost and point-of-care detection of biomarkers. Objective #1: Development of reproducible and ultrasensitive electrochemical nano-biosensors; Objective #2: Development of capillary microfluidic components and the CAMEN platform; Objective #3: Employment of the CAMEN platform for detecting biomarkers in spiked/clinical samples. At the end of the two years, we will demonstrate the production of novel compositions of conductive nanomaterials/inks and their screen-printing on flexible substrates, enabling the conversion of electrodes to electrochemical nano-biosensors in one single step. The project will also lead to the development of a new microfluidic platform with a developed library of characterized capillary microfluidic components, and once combined, can automate complex protocols of electrochemical biosensing into one single chip. Our proposed CAMEN-based bioassays would 1) be automated and quantitative sample-to-result tests, 2) be modular and easily adaptable for making new assays, 3) have multiplexing capability for detecting various types of biomarkers simultaneously in one single kit, 4) be rapid (<20 min) and low-cost (<$15-20), and 5) be compatible with digital health monitoring due to the wireless signal transfer to Web-App and Cloud-systems, aligned with the needs of emerging digital health platforms in Canada. This project will lead to economic benefits to Canada by creating demands for Canada's products and IPs related to micro- and nano-technologies, diagnostic platforms, and medical devices.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
561146-2020
Name nom
Sanati Nezhad, Amir
Department département
Mechanical and Manufacturing Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2100
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical engineering
Research subject fr
Génie mécanique
Installment
inst:2
Partie
1
Nb partie
2
Application title
Autonomous microfluidic electrochemical nano-biosensors for highly sensitive and selective detection and monitoring of biomarkers
Keyword
NSERC
Application summary
The present point-of-care assays and devices developed for rapid detection of biofluid markers are dealing with at least one of the challenges of automation, multiplexing, quantitative measurement, reproducibility, scalability, or cost. This project aims to develop a new scalable and reproducible CApillary Microfluidic Electrochemical Nano-biosensing (CAMEN) platform which enables full automation of complex quantitative bioassays for low-cost and point-of-care detection of biomarkers. Objective #1: Development of reproducible and ultrasensitive electrochemical nano-biosensors; Objective #2: Development of capillary microfluidic components and the CAMEN platform; Objective #3: Employment of the CAMEN platform for detecting biomarkers in spiked/clinical samples. At the end of the two years, we will demonstrate the production of novel compositions of conductive nanomaterials/inks and their screen-printing on flexible substrates, enabling the conversion of electrodes to electrochemical nano-biosensors in one single step. The project will also lead to the development of a new microfluidic platform with a developed library of characterized capillary microfluidic components, and once combined, can automate complex protocols of electrochemical biosensing into one single chip. Our proposed CAMEN-based bioassays would 1) be automated and quantitative sample-to-result tests, 2) be modular and easily adaptable for making new assays, 3) have multiplexing capability for detecting various types of biomarkers simultaneously in one single kit, 4) be rapid (<20 min) and low-cost (<$15-20), and 5) be compatible with digital health monitoring due to the wireless signal transfer to Web-App and Cloud-systems, aligned with the needs of emerging digital health platforms in Canada. This project will lead to economic benefits to Canada by creating demands for Canada's products and IPs related to micro- and nano-technologies, diagnostic platforms, and medical devices.